These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2908104)

  • 1. HLA class II DNA genotypes in Graves' disease: clues to inheritance of the HLA-linked component of susceptibility.
    Fletcher J; Franklyn JA; McLachlan SM; Young E; Sheppard MC
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):539-47. PubMed ID: 2908104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus.
    Garcia-Ameijeiras A; Gladman DD; Chan JY; Volpé R
    Clin Invest Med; 1993 Oct; 16(5):326-32. PubMed ID: 7903231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage of HLA-DR beta specific restriction fragment length polymorphisms with Graves' disease.
    Boehm BO; Schifferdecker E; Kuehnl P; Schöffling K
    Acta Endocrinol (Copenh); 1988 Oct; 119(2):251-6. PubMed ID: 2902722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24.
    Semana G; Allanic H; Quillivic F; Vallejo MT; Simon JP; Genetet B; Fauchet R
    Hum Immunol; 1990 Oct; 29(2):143-9. PubMed ID: 1979072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetics of Graves' ophthalmopathy.
    Weetman AP; So AK; Warner CA; Foroni L; Fells P; Shine B
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):619-28. PubMed ID: 2908181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes.
    Mangklabruks A; Cox N; DeGroot LJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):236-44. PubMed ID: 1677360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.
    Heward JM; Allahabadia A; Sheppard MC; Barnett AH; Franklyn JA; Gough SC
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):115-8. PubMed ID: 10468973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C4A gene deletion: association with Graves' disease.
    Ratanachaiyavong S; Lloyd L; McGregor AM
    J Mol Endocrinol; 1989 Sep; 3(2):145-53. PubMed ID: 2570594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC-extended haplotypes in families of patients with Graves' disease.
    Ratanachaiyavong S; Lloyd L; Darke C; McGregor AM
    Hum Immunol; 1993 Feb; 36(2):99-111. PubMed ID: 8096501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects.
    Cavan DA; Penny MA; Jacobs KH; Kelly MA; Jenkins D; Mijovic C; Chow C; Cockram CS; Hawkins BR; Barnett AH
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):63-6. PubMed ID: 8306482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
    Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
    Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of HIV-related disease is associated with HLA DQ and DR alleles defined by restriction fragment length polymorphisms.
    Donald JA; Rudman K; Cooper DW; Baumgart KW; Garsia RJ; Gatenby PA; Rickard KA
    Tissue Antigens; 1992 May; 39(5):241-8. PubMed ID: 1357776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
    Michelsen B; Lernmark A
    J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DQA2 U allele: a genetic marker for relapse of Graves' disease.
    Ratanachaiyavong S; Gunn CA; Bidwell EA; Darke C; Hall R; McGregor AM
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):241-51. PubMed ID: 1971775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.
    Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Yamauchi K; Itatsu T; Takatsuki K; Saito H
    J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
    La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
    Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10.
    Bidwell JL; Bidwell EA; Savage DA; Middleton D; Klouda PT; Bradley BA
    Transplantation; 1988 Mar; 45(3):640-6. PubMed ID: 2894727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR and DQ DNA genotyping in multiple sclerosis patients in Northern Ireland.
    Cullen CG; Middleton D; Savage DA; Hawkins S
    Hum Immunol; 1991 Jan; 30(1):1-6. PubMed ID: 1672121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against extended DR3-related haplotypes in Graves' disease.
    Weetman AP; McCorkle R
    J Immunogenet; 1990 Dec; 17(6):403-7. PubMed ID: 1982883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of class II DNA restriction fragments with responsiveness to Ambrosia artemisiifolia (short ragweed)-pollen allergen Amb a V in ragweed-allergic patients.
    Zwollo P; Ansari AA; Marsh DG
    J Allergy Clin Immunol; 1989 Jan; 83(1):45-54. PubMed ID: 2563269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.